Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rubin

Showing results (91-100 of 785) with videos related to

Pageof 79
Sort By:
Acta Endocrinologica|December 1, 1989
Relationship of nocturnal plasma bioactive and immunoactive ACTH concentrations to cortisol secretion in normal menR E Poland, K Hanada, R T Rubin
Perspectives in Biology and Medicine|November 11, 2008
Medical professionalism and the doctor-patient relationshipLydia S Dugdale, Mark Siegler, David T Rubin
Current Osteoporosis Reports|February 2, 2013
The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosisM Ete Chan, Gunes Uzer, Clinton T Rubin
Gastroenterology & Hepatology|April 26, 2014
Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammationJami A Kinnucan, David T Rubin, Tauseef Ali
ACG Case Reports Journal|February 2, 2017
Two Complex Cases of Hermansky-Pudlak Syndrome Highlight a Potential Biologic Explanation for an Associated Crohn's Disease PhenotypeM Anthony Sofia, Atsushi Sakuraba, David T Rubin
Biochimica Et Biophysica Acta|January 14, 1981
Experimental and theoretical considerations of mechanisms controlling cation effects on thylakoid membrane stacking and chlorophyll fluorescenceB T Rubin, W S Chow, J Barber
Expert Review of Gastroenterology & Hepatology|October 10, 2024
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidaysJoëlle St-Pierre, Asher Shafrir, David T Rubin
Alimentary Pharmacology & Therapeutics|January 25, 2011
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysisG R Lichtenstein, D Ramsey, D T Rubin
World Journal of Gastrointestinal Endoscopy|March 23, 2022
Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forgetPaulina Núñez F, Rodrigo Quera, David T Rubin
Gene|May 12, 2012
Mechanical regulation of signaling pathways in boneWilliam R Thompson, Clinton T Rubin, Janet Rubin
Pageof 79

Showing results (91-100 of 785) with videos related to

Sort By:
Pageof 79
Acta Endocrinologica|December 1, 1989
Relationship of nocturnal plasma bioactive and immunoactive ACTH concentrations to cortisol secretion in normal menR E Poland, K Hanada, R T Rubin
Perspectives in Biology and Medicine|November 11, 2008
Medical professionalism and the doctor-patient relationshipLydia S Dugdale, Mark Siegler, David T Rubin
Current Osteoporosis Reports|February 2, 2013
The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosisM Ete Chan, Gunes Uzer, Clinton T Rubin
Gastroenterology & Hepatology|April 26, 2014
Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammationJami A Kinnucan, David T Rubin, Tauseef Ali
ACG Case Reports Journal|February 2, 2017
Two Complex Cases of Hermansky-Pudlak Syndrome Highlight a Potential Biologic Explanation for an Associated Crohn's Disease PhenotypeM Anthony Sofia, Atsushi Sakuraba, David T Rubin
Biochimica Et Biophysica Acta|January 14, 1981
Experimental and theoretical considerations of mechanisms controlling cation effects on thylakoid membrane stacking and chlorophyll fluorescenceB T Rubin, W S Chow, J Barber
Expert Review of Gastroenterology & Hepatology|October 10, 2024
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidaysJoëlle St-Pierre, Asher Shafrir, David T Rubin
Alimentary Pharmacology & Therapeutics|January 25, 2011
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysisG R Lichtenstein, D Ramsey, D T Rubin
World Journal of Gastrointestinal Endoscopy|March 23, 2022
Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forgetPaulina Núñez F, Rodrigo Quera, David T Rubin
Gene|May 12, 2012
Mechanical regulation of signaling pathways in boneWilliam R Thompson, Clinton T Rubin, Janet Rubin
Pageof 79